1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, Y; Mei, M; Shen, B; Wu, X; Zhao, H; Zhou, S | 1 |
1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Ischemia
Article | Year |
---|---|
TRPC6 May Protect Renal Ischemia-Reperfusion Injury Through Inhibiting Necroptosis of Renal Tubular Epithelial Cells.
Topics: Apoptosis; Benzylamines; Blotting, Western; Cell Line; Cell Shape; Down-Regulation; Epithelial Cells; Fluorescent Antibody Technique; Humans; Imidazoles; Ischemia; Kidney Tubules; Necrosis; Oxygen; Protective Agents; Reperfusion Injury; RNA, Small Interfering; Sulfonamides; TRPC Cation Channels; TRPC6 Cation Channel; Up-Regulation | 2016 |